Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Challice L Bonifant

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal for Immunotherapy of Cancer|December 13, 2021
Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicitiesIlias Christodoulou, Won Jin Ho, Andrew Marple, et al.
Frontiers in Immunology|June 29, 2026
Case Report: Bilateral optic nerve head masses and retinopathy in a patient with B-cell acute lymphoblastic leukemia receiving CAR T-cell therapy masquerading as fungal endophthalmitisJacob S Heng, Eugenia Ramos-Davila, Alejandra M Maiz, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
B7-H3-targeted natural killer cells effectively kill atypical teratoid / rhabdoid tumors and extend survival in orthotopic xenograftsJun Choe, Sachiv Chakravarti, Natalie J Holl, et al.
Nature Biomedical Engineering|April 16, 2021
Converging genetic and epigenetic drivers of paediatric acute lymphoblastic leukaemia identified by an information-theoretic analysisMichael A Koldobskiy, Garrett Jenkinson, Jordi Abante, et al.
Nature Communications|January 3, 2023
The rapid and highly parallel identification of antibodies with defined biological activities by SLISYSteve Lu, Austin K Mattox, P Aitana Azurmendi, et al.
Journal of the American Chemical Society|April 14, 2005
Chemistry of the diazeniumdiolates: Z right harpoon over left harpoon E isomerismYan-Ni Wang, D Scott Bohle, Challice L Bonifant, et al.
Cancer Research Communications|August 26, 2024
Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R DomainStamatia C Vorri, Natalie J Holl, Michael Leeming, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionalityRuyan Rahnama, Monika Kizerwetter, Huilin Yang, et al.
Molecular Cancer Therapeutics|April 18, 2003
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activityPaul J Shami, Joseph E Saavedra, Lai Y Wang, et al.
Blood Advances|January 24, 2024
Longitudinal plasma proteomics in CAR T-cell therapy patients implicates neutrophils and NETosis in the genesis of CRSChristopher Flora, Mary Olesnavich, Yu Zuo, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|December 13, 2021
Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicitiesIlias Christodoulou, Won Jin Ho, Andrew Marple, et al.
Frontiers in Immunology|June 29, 2026
Case Report: Bilateral optic nerve head masses and retinopathy in a patient with B-cell acute lymphoblastic leukemia receiving CAR T-cell therapy masquerading as fungal endophthalmitisJacob S Heng, Eugenia Ramos-Davila, Alejandra M Maiz, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
B7-H3-targeted natural killer cells effectively kill atypical teratoid / rhabdoid tumors and extend survival in orthotopic xenograftsJun Choe, Sachiv Chakravarti, Natalie J Holl, et al.
Nature Biomedical Engineering|April 16, 2021
Converging genetic and epigenetic drivers of paediatric acute lymphoblastic leukaemia identified by an information-theoretic analysisMichael A Koldobskiy, Garrett Jenkinson, Jordi Abante, et al.
Nature Communications|January 3, 2023
The rapid and highly parallel identification of antibodies with defined biological activities by SLISYSteve Lu, Austin K Mattox, P Aitana Azurmendi, et al.
Journal of the American Chemical Society|April 14, 2005
Chemistry of the diazeniumdiolates: Z right harpoon over left harpoon E isomerismYan-Ni Wang, D Scott Bohle, Challice L Bonifant, et al.
Cancer Research Communications|August 26, 2024
Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R DomainStamatia C Vorri, Natalie J Holl, Michael Leeming, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionalityRuyan Rahnama, Monika Kizerwetter, Huilin Yang, et al.
Molecular Cancer Therapeutics|April 18, 2003
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activityPaul J Shami, Joseph E Saavedra, Lai Y Wang, et al.
Blood Advances|January 24, 2024
Longitudinal plasma proteomics in CAR T-cell therapy patients implicates neutrophils and NETosis in the genesis of CRSChristopher Flora, Mary Olesnavich, Yu Zuo, et al.
Pageof 5